← Leaderboards
Martin D Hill
Ponce School Of Medicine
$1,738,568
Attributed
$1,738,568
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $282.2K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,738,568 · 3
By mechanism
SC3$950,886 · 1
S06$787,682 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antiretroviral Therapy”
- James Dennis Neaton · Northwestern University$279,044,427
- Lawrence Corey · Fred Hutchinson Cancer Center$278,220,635
- Constance Ann Benson · University Of California, San Diego$241,336,455
- Carol Nesel · Westat$188,148,170
- Judith S. Currier · University Of California Los Angeles$182,467,520
- Barbara Driver · Westat, Inc.$170,789,549
Research focus
Antiretroviral TherapyPlasmaViralViral Load ResultVirus DiseasesViremiaSamplingSourceVirusBloodLaboratoriesInfectionLymphocyteCellsGenotypeVisitAntiviral AgentsDrug ResistanceProceduresDetectionHiv InfectionsLongitudinal Human StudyLiquid SubstanceAnti-Retroviral Agents
Grant awards (18)
HIV infection of decidual macrophages during suppressive antiretroviral therapy$120,820
SC3 · FY2017 · GM · contact PI
HIV infection of decidual macrophages during suppressive antiretroviral therapy$120,820
SC3 · FY2016 · GM · contact PI
HIV infection of decidual macrophages during suppressive antiretroviral therapy$120,820
SC3 · FY2015 · GM · contact PI
HIV infection of decidual macrophages during suppressive antiretroviral therapy$120,820
SC3 · FY2014 · GM · contact PI
Origin of Seminal Virus in Human Immunodeficiency Virus Infection$116,314
SC3 · FY2012 · GM · contact PI
Origin of Seminal Virus in Human Immunodeficiency Virus Infection$116,314
SC3 · FY2011 · GM · contact PI
Origin of Seminal Virus in Human Immunodeficiency Virus Infection$117,489
SC3 · FY2010 · GM · contact PI
Origin of Seminal Virus in Human Immunodeficiency Virus Infection$117,489
SC3 · FY2009 · GM · contact PI
Seminal Compartment as a Drug Sanctuary and Potential Reservoir in HIV Infection$282,151
S06 · FY2008 · GM · contact PI
Seminal Compartment as a Drug Sanctuary and Potential Reservoir in HIV Infection$279,964
S06 · FY2007 · GM · contact PI
Seminal Compartment as a Drug Sanctuary and Potential Reservoir in HIV Infection$122,075
S06 · FY2006 · GM · contact PI
Seminal Compartment as a Drug Sanctuary and Potential Reservoir in HIV Infection$103,492
S06 · FY2005 · GM
Resistance Mutations &Nonadherence in HIV THER FAILURE$0
S06 · FY2002 · GM
Resistance Mutations &Nonadherence in HIV THER FAILURE$0
S06 · FY2002 · GM
Resistance Mutations &Nonadherence in HIV THER FAILURE$0
S06 · FY2002 · GM
Resistance Mutations &Nonadherence in HIV THER FAILURE$0
S06 · FY2002 · GM
Resistance Mutations &Nonadherence in HIV THER FAILURE$0
S06 · FY2002 · GM
Resistance Mutations &Nonadherence in HIV THER FAILURE$0
S06 · FY2001 · GM